Osteonecrosis of the Jaw After Bisphosphonates Treatment in Patients with Multiple Myeloma

Journal
Medical archives (Sarajevo, Bosnia and Herzegovina)
Date Issued
2015-12
Author(s)
Cevrevska, Lidija
Georgjievski, Borce
Abstract
Bone lytic lesion in Multiple myeloma are the most commonly presented symptoms which require treatment with bisphosphonates (BPs). BPs are providing supportive care, reducing the rate of skeletal morbidity but evidently not abolishing it, the criteria for stopping their administration have to be different from those used for classic antineoplastic drugs, and they should not be stopped when metastatic bone disease is progressing. Osteonecrosis of the jaw (ONJ) has been associated recently with the use of BPs.
File(s)
Loading...
Thumbnail Image
Name

Osteonecrosis of the Jaw After Bisphosphonates Treatment in Patients with Multiple Myeloma.pdf

Size

301.65 KB

Format

Adobe PDF

Checksum

(MD5):e632d5c94d06bbcd0e92fe03bbb11040